Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway

SIMPLE SUMMARY: Ovarian cancer is a deadly cancer due to its late diagnosis. Despite aggressive surgery and chemotherapy recurrence of a resistant aggressive disease is common. Thus, there is an unmet need to develop new therapeutics that target cancer cells and prevent recurrence and resistance. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghoneum, Alia, Gonzalez, Daniela, Afify, Hesham, Shu, Junjun, Hegarty, Abigail, Adisa, Jemima, Kelly, Michael, Lentz, Samuel, Salsbury, Freddie, Said, Neveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600774/
https://www.ncbi.nlm.nih.gov/pubmed/36291886
http://dx.doi.org/10.3390/cancers14205099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600774/
https://www.ncbi.nlm.nih.gov/pubmed/36291886
http://dx.doi.org/10.3390/cancers14205099

Ejemplares similares